분자 운송 배지 시장 : 세계 업계 분석, 규모, 점유율, 성장, 동향, 예측(2031년) - 제품 유형별, 용도별, 샘플별, 최종사용자별, 지역별
Molecular Transport Medium Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)
상품코드:1397264
리서치사:Fairfield Market Research
발행일:2023년 12월
페이지 정보:영문 336 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 분자 운송 배지 시장 규모는 2021년에 16억 달러의 매출을 기록하며 일시적 침체를 경험했으나, 현재는 꾸준한 성장을 달성하고 있습니다. 예측에서 시장은 2031년까지 12억 달러에 달할 것으로 예측되고 있습니다.
기술의 발전으로 전통적인 운송 매체에서 혁신적인 분자 운송 매체로 전환하여 안전성과 편의성을 향상시키고 있습니다. 이러한 신제품은 운송, 보관 및 처리 과정에서 위험하지 않고 누출이 없는 포뮬러를 통해 노출 위험을 줄입니다.
시료 채취 후 시료의 열화 및 세포 사멸을 방지하기 위해서는 신속한 보존이 필수적이기 때문에 운송 및 보관 중 시료의 안정성을 유지하는 것도 중요한 원동력이 되고 있습니다. 분자 운송 배지는 저장 및 운송 중 시료의 안정성을 약 48시간 동안 유지하여 냉동 및 해동의 필요성을 피하는 데 중요한 역할을 합니다.
시료 안정화를 위한 대체 솔루션, 특히 바이러스, 박테리아, 곰팡이 검출을 위한 대체 솔루션은 분자 운송 배지 시장의 도전 과제입니다. 이러한 용액은 중성 pH를 유지하기 위해 식염수나 완충염 용액을 사용하는 경우가 많습니다. 연구자들은 바이러스의 안정성을 높이기 위해 식물성 단백질 보충제를 찾고 있습니다.
세계의 분자 운송 배지 시장에 대해 조사했으며, 시장의 개요와 제품 유형별, 용도별, 샘플별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업의 경쟁 동향 등을 제공하고 있습니다.
목차
제1장 주요 요약
제2장 시장 개요
시장의 정의와 세분화
시장 역학
밸류체인 분석
Porter's Five Forces 분석
COVID-19의 영향 분석
우크라이나와 러시아의 분쟁의 영향
경제 개요
PESTLE 분석
제3장 세계의 분자 운송 배지 시장 전망, 2018-2031년
세계의 분자 운송 배지 시장 전망, 제품 유형별, 금액(10억 달러), 2018-2031년
세계의 분자 운송 배지 시장 전망, 용도별, 금액(10억 달러), 2018-2031년
세계의 분자 운송 배지 시장 전망, 샘플별, 금액(10억 달러), 2018-2031년
세계의 분자 운송 배지 시장 전망, 최종사용자별, 금액(10억 달러), 2018-2031년
세계의 분자 운송 배지 시장 전망, 지역별, 금액(10억 달러), 2018-2031년
제4장 북미의 분자 운송 배지 시장 전망, 2018-2031년
제5장 유럽의 분자 운송 배지 시장 전망, 2018-2031년
제6장 아시아태평양의 분자 운송 배지 시장 전망, 2018-2031년
제7장 라틴아메리카의 분자 운송 배지 시장 전망, 2018-2031년
제8장 중동 및 아프리카의 분자 운송 배지 시장 전망, 2018-2031년
제9장 경쟁 구도
샘플별과 용도별 히트맵
제조업체와 용도별 히트맵
기업의 시장 점유율 분석, 2023년
경쟁력 대시보드
기업 개요
Thermo Fisher Scientific Inc.
Becton, Dickinson, and Company
Cardinal Health
Quidel Corporation
Medical Wire & Equipment
COPAN Diagnostics Inc.
Titan Biotech Ltd.
Alpha Teknova, Inc.
Bio-Genex Laboratories Inc.
EKF Diagnostics
제10장 부록
KSA
영문 목차
영문목차
The global molecular transport medium market, which recorded revenues of US$ 1.6 billion in 2021, experienced a temporary dip but is now poised for steady growth. Projections indicate the market reaching US$ 1.2 billion by 2031.
Fueling Growth for Molecular Transport Medium Manufacturers
Innovative Technology - Revolutionizing Viral Transport Mediums
Technological advancements have led to a shift from traditional transport mediums to innovative molecular transport mediums, offering enhanced safety and convenience. These new products reduce exposure risks with non-hazardous and leak-proof formulations for transport, storage, and processing.
Preserving sample stability during transport and storage is another critical driver, as rapid storage is vital to prevent degradation or cell death after sample collection. Molecular transport mediums play a crucial role in maintaining sample stability during storage and transportation for approximately 48 hours, avoiding the need for freezing and thawing.
Challenges to Market Expansion
Presence of Alternative Technologies
Alternative solutions for stabilizing specimens, particularly for virus, bacteria, and fungus detection, pose a challenge to the molecular transport medium market. These solutions often use saline or buffered salt solutions to maintain a neutral pH. Researchers are exploring plant-based protein supplements to enhance virus stability.
Seasonal infections and the unpredictability of disease outbreaks affect demand for molecular transport mediums. Public awareness campaigns have increased testing rates, but demand may still outstrip supply due to the sporadic nature of infections.
Shelf-life limitations also hinder market growth, as molecular transport mediums have a short storage duration.
Country-wise Insights
U.S. Market: A Lucrative Opportunity
High awareness of disease prevention benefits, the presence of key players, and increased healthcare expenditure drive the demand for molecular transport mediums in the U.S.
Germany Market: Riding the Wave of Innovation
The launch of novel viral transport mediums, such as Thermo Fisher Scientific Inc.'s InhibiSURE, has boosted sales in European countries, including Germany, by ensuring rapid inactivation of the COVID-19 virus during collection and transport.
China Market: Government Investment
Major government investments have prompted manufacturers to increase production capacity to meet surging demand for comprehensive testing of symptomatic and asymptomatic patients, driven by COVID-19 and other infectious diseases.
India Market: Focus on Genetic Research
India's focus on genetic research and innovative product development for biological sample storage and transport, exemplified by Azooka Labs' mWRAPR, has fueled market growth. mWRAPR, India's first local biological storage and transport medium, has garnered support from institutions like Honeywell and Citigroup.
Competitive Landscape
Leading market players are expanding their production capacities to meet high demand during peak periods and offering competitive pricing. They are also developing advanced products to attract more end-users and increase market share.
Key Companies Profiled
Thermo Fisher Scientific Inc.
Becton, Dickinson, and Company
Cardinal Health
Quidel Corporation
Medical Wire & Equipment
COPAN Diagnostics Inc.
Titan Biotech Ltd.
Alpha Teknova, Inc. (formerly named Teknova)
Bio-Genex Laboratories Inc.
EKF Diagnostics
Trinity Biotech
Alpha-Tec Systems, Inc.
Charm Sciences, Inc.
Azer Scientific
bioBoaVista
AccuGene
KSL Diagnostics
Puritan Medical Products
Amazing Biotech (Shanghai) Co., Ltd.
Key Segments Covered in Molecular Transport Medium Industry Research
Molecular Transport Medium Market by Product Type:
Active Transport Medium
Inactivated Transport Medium
Molecular Transport Medium Market by Application:
Virus
COVID-19
Middle East Respiratory Syndrome (MERS)
Influenza
Human Immunodeficiency Virus (HIV)
Rhinovirus
Adenovirus
Respiratory Syncytial Virus (RSV)
Bacteria
Staphylococcus Pneumonia
Haemophilus Influenza
Anthrax
Others
Atypical Bacteria
Mycoplasma
Q-Fever
Others
Mycobacterial and Fungal Infection
Molecular Transport Medium Market by Sample:
Nasal Washes and Swabs
Sputum
Saliva
Faecal & Stool
Urine
Blood
Tissues
Others
Molecular Transport Medium Market by End User:
Diagnostic Laboratories
Microbiology Laboratories
Hospitals & Clinics
Others
Molecular Transport Medium Market by Region:
North America Molecular Transport Medium Market
Latin America Molecular Transport Medium Market
Europe Molecular Transport Medium Market
South Asia Molecular Transport Medium Market
East Asia Molecular Transport Medium Market
Oceania Molecular Transport Medium Market
The Middle East & Africa Molecular Transport Medium Market
Table of Contents
1. Executive Summary
1.1. Global Molecular Transport Medium Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Molecular Transport Medium Market Outlook, 2018 - 2031
3.1. Global Molecular Transport Medium Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Active Transport Medium
3.1.1.2. Inactivated Transport Medium
3.2. Global Molecular Transport Medium Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Virus
3.2.1.1.1. COVID-19
3.2.1.1.2. Middle East Respiratory Syndrome (MERS)
3.2.1.1.3. Influenza
3.2.1.1.4. Human Immunodeficiency Virus (HIV)
3.2.1.1.5. Rhinovirus
3.2.1.1.6. Adenovirus
3.2.1.1.7. Respiratory Syncytial Virus (RSV)
3.2.1.2. Bacteria
3.2.1.2.1. Staphylococcus Pneumonia
3.2.1.2.2. Haemophilus Influenza
3.2.1.2.3. Anthrax
3.2.1.2.4. Others
3.2.1.3. Atypical Bacteria
3.2.1.3.1. Mycoplasma
3.2.1.3.2. Q-Fever
3.2.1.3.3. Others
3.2.1.4. Mycobacterial and Fungal Infection
3.3. Global Molecular Transport Medium Market Outlook, by Sample, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Nasal Washes and Swabs
3.3.1.2. Sputum
3.3.1.3. Saliva
3.3.1.4. Faecal & Stool
3.3.1.5. Urine
3.3.1.6. Blood
3.3.1.7. Tissues
3.3.1.8. Others
3.4. Global Molecular Transport Medium Market Outlook, by By End User, Value (US$ Bn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. Diagnostic Laboratories
3.4.1.2. Microbiology Laboratories
3.4.1.3. Hospitals & Clinics
3.4.1.4. Others
3.5. Global Molecular Transport Medium Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Molecular Transport Medium Market Outlook, 2018 - 2031
4.1. North America Molecular Transport Medium Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Active Transport Medium
4.1.1.2. Inactivated Transport Medium
4.2. North America Molecular Transport Medium Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Virus
4.2.1.1.1. COVID-19
4.2.1.1.2. Middle East Respiratory Syndrome (MERS)
4.2.1.1.3. Influenza
4.2.1.1.4. Human Immunodeficiency Virus (HIV)
4.2.1.1.5. Rhinovirus
4.2.1.1.6. Adenovirus
4.2.1.1.7. Respiratory Syncytial Virus (RSV)
4.2.1.2. Bacteria
4.2.1.2.1. Staphylococcus Pneumonia
4.2.1.2.2. Haemophilus Influenza
4.2.1.2.3. Anthrax
4.2.1.2.4. Others
4.2.1.3. Atypical Bacteria
4.2.1.3.1. Mycoplasma
4.2.1.3.2. Q-Fever
4.2.1.3.3. Others
4.2.1.4. Mycobacterial and Fungal Infection
4.3. North America Molecular Transport Medium Market Outlook, by Sample, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Nasal Washes and Swabs
4.3.1.2. Sputum
4.3.1.3. Saliva
4.3.1.4. Faecal & Stool
4.3.1.5. Urine
4.3.1.6. Blood
4.3.1.7. Tissues
4.3.1.8. Others
4.4. North America Molecular Transport Medium Market Outlook, by By End User, Value (US$ Bn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. Diagnostic Laboratories
4.4.1.2. Microbiology Laboratories
4.4.1.3. Hospitals & Clinics
4.4.1.4. Others
4.5. North America Molecular Transport Medium Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.5.1. Key Highlights
4.5.1.1. U.S. Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
4.5.1.2. U.S. Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
4.5.1.3. U.S. Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
4.5.1.4. U.S. Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
4.5.1.5. Canada Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
4.5.1.6. Canada Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
4.5.1.7. Canada Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
4.5.1.8. Canada Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
